# Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection

> **NCT00002078** · PHASE1 · COMPLETED · sponsor: **Purdue Frederick**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Interferon alfa-n3

## Key facts

- **NCT ID:** NCT00002078
- **Lead sponsor:** Purdue Frederick
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002078, "Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*